Chemoprevention of Lung Pathologies by Dietary n-3 Polyunsaturated Fatty Acids
Keywords: (ALI); (ARDS); (CFTR); (COPD); (NF-B); (PPAR-); (cftr/ mice); ALI; ARDS; COPD; Caenorhabditis elegans; Caucasians; Chemoprevention; Docosanoids; Eicosanoid; Eicosapentaenoic acid; IL-8; LUNG CANCER; Lung injury; Polyunsaturated Fatty Acids; Tumor Necrosis Factor; acute respiratory distress syndrome; airway inflammation; anti-inflammatory; asthma; cachexia; cancer; chemotherapy; cystic fibrosis; docosahex-aenoic acid; fat-1; inflammation; interstitial lung diseases; interstitial lung diseases, lung; linolenic acid; lung; lung cancer; lung injury; maresins; n-3 PUFAs; pathology; protectins; pulmonary fibrosis; resolvins; smokin
Document Type: Research Article
Publication date: 2010-10-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.